US Patent 9204624 Non-human animals with modifed immunoglobulin heavy chain sequences
Patent 9204624 was granted and assigned to Regeneron Pharmaceuticals on December, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 26, 2014
Date of Patent
December 8, 2015
Patent Applicant
Patent Application Number
14498523
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9204624 Non-human animals with modifed immunoglobulin heavy chain sequences
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.